UCLA Research Program in Pharmaceutical Economics and Policy
Parent: UCLA
eScholarship stats: Breakdown by Item for June through September, 2026
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 5fg9n284 | Drug Evaluations: Type I vs. Type II Errors | 171 | 28 | 143 | 16.4% |
| 85s5w09k | Pharmaceutical Prices and Expenditures | 117 | 24 | 93 | 20.5% |
| 5d8758z2 | The Pharmaceutical Research and Development Process, and its Costs | 100 | 17 | 83 | 17.0% |
| 0d90459k | The Productivity of Health Care and Pharmaceuticals: An International Comparison | 86 | 18 | 68 | 20.9% |
| 46p5p6p4 | Do Managed Care Drug Formularies Signal Health Plan Coverage Generosity | 81 | 15 | 66 | 18.5% |
| 7vz4h41m | Differences in Managed Care Drug Formularies: What Can Consumers Learn? | 63 | 15 | 48 | 23.8% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.